News

The Economic Times, 9 Nov, 10:56

Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoY

Gland Pharma shares rose 3.89% after reporting strong Q2 FY27 results, with revenue growing 23% and net profit jumping 58% year-on-year. The stock touched a 52-week high of Rs 3,345, supported by robust CDMO growth,…

Read the full story on The Economic Times

Headline, summary and picture belong to The Economic Times, from its public news feed. We don’t copy the article; the full text is on The Economic Times’s site. Prices: Yahoo Finance, delayed.

• Up 118% in 6 months! This volume shocker pharma stock skyrockets 14% despite weak trends on Dalal Street Do you own?

  Mint, 9 Nov, 11:34

  

• Gland Pharma shares hit 52-week high; jump 7% despite market sell-off | Will rally continue after 93% YTD rise?

  Mint, 9 Nov, 10:19

  

• Divi's Laboratories shares hit record high rising 84% YTD; buy, sell or hold after Q2 results 2026? Brokerages report

  Mint, 9 Nov, 10:18

  Divi's Laboratories+3.24%
  

• Nifty slips below 25,000 as IT, power stocks drag; banks, pharma hold firm

  BusinessLine, 9 Nov, 09:51

  

• Divi's Laboratories shares gain 6% after JPMorgan upgrade; Goldman raises earnings estimates after strong Q2

  CNBC-TV18, 9 Nov, 09:32

  Divi's Laboratories+3.24%
  

• Cipla Share Price Live Updates: Cipla's Price Movement Signals Caution

  The Economic Times, 9 Nov, 08:30

  Cipla−0.06%